Trial Profile
An observational time and motion study of denosumab subcutaneous injection and zoledronic acid intravenous infusion in patients with metastatic bone disease: Results from Belgium, Germany and Italy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Nov 2017
Price :
$35
*
At a glance
- Drugs Denosumab (Primary) ; Zoledronic acid (Primary)
- Indications Bone metastases
- Focus Therapeutic Use
- 22 Jan 2016 New trial record